Maryland Tech Council Announces 2024 ICON Awards Finalists Current FITCI client NanoBioFAB earned a spot in two categories of the The Maryland Tech Council’s (MTC) 2024 awards. MTC, the largest … Read more

Theradaptive can now enroll patients at each site in Australia listed with Bellberry as part of its global clinical study for OsteoAdapt SP. FREDERICK, Md., Feb. 27, 2024 — Theradaptive, a … Read more

FREDERICK, MD —Kenneth Dretchen, PhD, of Mesa Science Associates, in collaboration with researchers from Bryn Pharma LLC, Celerion Inc., and Allucent, recently published an article in the Journal of Allergy and … Read more

Global study will assess the safety and efficacy of the company’s lead spinal fusion product, OsteoAdapt SP FREDERICK, Md., Feb. 1, 2024  — FITCI graduate Theradaptive, the market leader in targeted regenerative … Read more

FREDERICK MD – KnowledgeNet.ai, a leading provider of artificial intelligence solutions, proudly announces a significant milestone in its continued growth and market presence. The company has reached its 20th Customer … Read more

1/05/2024 – Frederick Innovative Technology Center, Inc. (FITCI) is a business incubator and accelerator designed to cultivate entrepreneurship in Frederick, Maryland. It offers coaching, connections, access to capital, and customers … Read more

We are excited to announce, that Meridian BioGroup has been acquired by Pace® Life Sciences. The acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the … Read more

Frederick, MD – HBVtech, a biopharma startup company within the Frederick Innovation Technology Center (FITCI), is garnering international attention for its work creating a single-dose injection-based hepatitis B cure. Founder … Read more

Columbia, MD, July 18, 2022 – Hawkeye Med Tech, Inc, a Maryland Medtech company has partnered with the Kiosk Group, Ltd,. to produce one-of-a-kind Portable TotalCare Telehealth StationTM or PTTS. PTTS is … Read more

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of Health (NIH) entitled “Development of Cobinamide as a Novel Treatment … Read more